1273 related articles for article (PubMed ID: 22435567)
1. NF-κB and the link between inflammation and cancer.
DiDonato JA; Mercurio F; Karin M
Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
[TBL] [Abstract][Full Text] [Related]
2. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
Manna SK; Gangadharan C
Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
[TBL] [Abstract][Full Text] [Related]
3. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
Wong ET; Tergaonkar V
Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB in cancer--a friend turned foe.
Ravi R; Bedi A
Drug Resist Updat; 2004 Feb; 7(1):53-67. PubMed ID: 15072771
[TBL] [Abstract][Full Text] [Related]
5. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
6. Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part I.
Wilczynski J; Duechler M; Czyz M
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):289-99. PubMed ID: 21625848
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappaB in development, prevention, and therapy of cancer.
Van Waes C
Clin Cancer Res; 2007 Feb; 13(4):1076-82. PubMed ID: 17317814
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation.
Blander JM
Methods Mol Biol; 2009; 512():99-117. PubMed ID: 19347275
[TBL] [Abstract][Full Text] [Related]
9. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
10. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA
Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor growth by NF-kappaB inhibitors.
Umezawa K
Cancer Sci; 2006 Oct; 97(10):990-5. PubMed ID: 16925581
[TBL] [Abstract][Full Text] [Related]
12. Aberrant rel/nfkb genes and activity in human cancer.
Rayet B; Gélinas C
Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB: tumor promoter or suppressor?
Perkins ND
Trends Cell Biol; 2004 Feb; 14(2):64-9. PubMed ID: 15102437
[TBL] [Abstract][Full Text] [Related]
14. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).
Zhang Z; Rigas B
Int J Oncol; 2006 Jul; 29(1):185-92. PubMed ID: 16773199
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
17. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB and IKK as therapeutic targets in cancer.
Kim HJ; Hawke N; Baldwin AS
Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
[TBL] [Abstract][Full Text] [Related]
19. Targeting NF-kappaB in hematologic malignancies.
Braun T; Carvalho G; Fabre C; Grosjean J; Fenaux P; Kroemer G
Cell Death Differ; 2006 May; 13(5):748-58. PubMed ID: 16498458
[TBL] [Abstract][Full Text] [Related]
20. Nuclear transcription factor-kappaB as a target for cancer drug development.
Garg A; Aggarwal BB
Leukemia; 2002 Jun; 16(6):1053-68. PubMed ID: 12040437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
